We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.6B
AUM Growth
+$29.8M
Cap. Flow
-$1.17B
Cap. Flow %
-4.59%
Top 10 Hldgs %
14.11%
Holding
1,418
New
109
Increased
422
Reduced
606
Closed
147

Top Buys

Rank Stock Value
1
JMIA
Jumia Technologies
JMIA
+$130M
2
NXPI icon
NXP Semiconductors
NXPI
+$55.3M
3
AZO icon
AutoZone
AZO
+$42.3M
4
ALC icon
Alcon
ALC
+$35.7M
5
INTU icon
Intuit
INTU
+$33.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$126M
2
BIDU icon
Baidu
BIDU
+$83.8M
3
ROK icon
Rockwell Automation
ROK
+$76.1M
4
AMZN icon
Amazon
AMZN
+$74.9M
5
XLNX
Xilinx Inc
XLNX
+$56.7M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 15.25%
3 Consumer Discretionary 10.67%
4 Financials 10.37%
5 Industrials 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAP
426
The Gap Inc
GAP
$7.3B
$11.2M 0.04%
625,300
-363,400
-37% -$8.15M
P
427
Everpure Inc
P
$23B
$11.2M 0.04%
734,253
-217,769
-23% -$4.25M
HYG icon
428
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$11.2M 0.04%
128,550
+2,200
+2% +$190K
RDN icon
429
Radian Group
RDN
$5.28B
$11.2M 0.04%
490,050
-102,950
-17% -$2.35M
ESNT icon
430
Essent Group
ESNT
$6.28B
$11.1M 0.04%
236,300
+76,300
+48% +$3.59M
CBIO
431
Crescent Biopharma
CBIO
$546M
$11.1M 0.04%
9,306
+55
+0.6% +$65.8K
NSC icon
432
Norfolk Southern
NSC
$75.4B
$11.1M 0.04%
55,560
-1,165
-2% -$231K
DOX icon
433
Amdocs
DOX
$6.03B
$11.1M 0.04%
178,246
+18,146
+11% +$1.05M
PCAR icon
434
PACCAR
PCAR
$70.5B
$11.1M 0.04%
231,596
-14,124
-6% -$656K
CXT icon
435
Crane NXT
CXT
$2.99B
$10.9M 0.04%
377,725
-23,320
-6% -$679K
ULTA icon
436
Ulta Beauty
ULTA
$21.8B
$10.9M 0.04%
31,402
+14,494
+86% +$5.01M
GWRE icon
437
Guidewire Software
GWRE
$13.9B
$10.9M 0.04%
+107,229
New +$10.9M
PEN icon
438
Penumbra
PEN
$12.6B
$10.8M 0.04%
67,760
+50,960
+303% +$7.36M
AIV
439
Aimco
AIV
$377M
$10.8M 0.04%
1,622,295
+504,637
+45% +$3.37M
MAR icon
440
Marriott International
MAR
$100B
$10.8M 0.04%
76,700
+9,600
+14% +$1.27M
RCI icon
441
Rogers Communications
RCI
$18.8B
$10.7M 0.04%
200,156
-183,100
-48% -$9.56M
MU icon
442
Micron Technology
MU
$835B
$10.7M 0.04%
277,300
-954,608
-77% -$36.4M
MLNX
443
DELISTED
Mellanox Technologies, Ltd.
MLNX
$10.6M 0.04%
96,000
-52
-0.1% -$5.99K
BF.B icon
444
Brown-Forman Class B
BF.B
$13.5B
$10.6M 0.04%
191,589
+10,528
+6% +$562K
NTRS icon
445
Northern Trust
NTRS
$21.8B
$10.5M 0.04%
117,000
-47,900
-29% -$4.41M
RNG icon
446
RingCentral
RNG
$4.83B
$10.5M 0.04%
91,566
-13,734
-13% -$1.58M
RDWR icon
447
Radware
RDWR
$983M
$10.5M 0.04%
425,000
+75,000
+21% +$1.87M
WFC icon
448
Wells Fargo
WFC
$254B
$10.5M 0.04%
221,934
-27,398
-11% -$1.28M
WDAY icon
449
Workday
WDAY
$41.5B
$10.5M 0.04%
50,979
-2,155
-4% -$435K
SGEN
450
DELISTED
Seagen Inc. Common Stock
SGEN
$10.5M 0.04%
151,381
+2,851
+2% +$200K

Similar funds

Axa's Q2 2019 Portfolio in Review

As of Q2 2019, Axa held 1,418 positions worth $25.6B, up 0.12% from $25.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa withdrew a net $1.17B in Q2 2019, closing 147 positions and reducing 606 holdings. Its most notable exit was Foot Locker, an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in Jumia Technologies worth $119M.

  • Axa's largest Q2 2019 buy was Jumia Technologies: 4,502,527 shares worth $119M.
  • Axa added most to NXP Semiconductors in Q2 2019, an estimated $55.3M increase.
  • Axa's biggest Q2 2019 reduction was Linde, cutting an estimated $126M.
  • Axa fully exited Foot Locker in Q2 2019, selling an estimated $10.1M.
  • Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q2 2019.
  • Axa opened 109 new positions and closed 147 in Q2 2019.
  • Axa's portfolio value rose 0.12% quarter-over-quarter to $25.6B.

Based on Axa's 13F filing for Q2 2019, filed 13 Aug 2019.